Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 3:44 PM UTC
| NCT Number | NCT05082519 |
| Recruiting Status | Recruiting |
| Condition | B-cell Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Etan Orgel |
| Last Updated on CT.gov | August 19, 2026 (2 weeks ago) |
As of September 2, 2026: Clinical trial NCT05082519 is currently recruiting participants. This phase2 study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 16 locations across the United States. The study is sponsored by Etan Orgel. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05082519 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05082519 was last updated 2 weeks ago (August 19, 2026). HelloStudys verifies this status automatically.